2022 was the biggest and most exciting year yet for PicnicHealth - not only for our team, but for our Change Champions, PicnicHealth users, and research partners. We want to thank everyone for being a part of this incredible community and making this past year possible.
Before we jump into 2023, join us as we look back at our favorite moments of last year.
We raised $60 million in Series C funding!
PicnicHealth is ecstatic to have raised a $60m Series C to help build deep, complete, and clinically-rich real-world datasets in several new diseases. The team spent the year growing our research program portfolio, connecting with new patient populations to initiate new studies; introducing new capabilities to our patient app to make it easier for patients to tell us more about their experiences by completing surveys, diaries, and more; and building new data features to help researchers gain new insights faster.
Learn more here
We reached greater heights:
{{yir-grid}}
New Partners
This year PicnicHealth announced an engagement with Bristol Myers Squibb to leverage real-world evidence to study symptomatic obstructive hypertrophic cardiomyopathy patients.
This engagement is designed to help Bristol Myers Squibb unlock new insights about long-term, real-world patient experiences within the DISCOVER-HCM Registry.
Read the full announcement here
New Research Presentations
With COVID regulations ending and more events taking place in person, the team, along with our research partners, were excited to attend conferences and present our research findings to our peers. Here are some highlights below.
{{yir-links}}
What we’re looking forward to in 2023
We’re thrilled to announce the launch of our new webinar series! This four-part series will bring together global stakeholders with diverse perspectives on real world evidence (RWE) to reframe the “ROI” for RWE generation and tackle the question: beyond the return on investment for RWE, what is the risk of inaction?
Join us on February 1st as we kick off the series. We have an impressive lineup of experts speaking on “The Transformational Value of Real-World Data for Drug Development and Regulatory Decision-Making”. You won’t want to miss Najat Khan, Jesper Kjaer, Noga Leviner and Evelyn Pyper discussing how a data-driven approach can drive impact across both research and clinical practice.
{{yir-register}}